Product Description: Alnuctamab (EM901) is an asymmetric 2-arm, humanized IgG T-cell engager (TCE). Alnuctamab can be used for immune research[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Danny V Jeyaraju, et al. Suppression of Myeloid Cell-Derived Proinflammatory Cytokines with Celmod Agents: Implications for CRS with T-Cell Engagers (TCEs). Blood (2022) 140 (Supplement 1): 7070–7071.